Clinical trial No longer in our active list Interventional Ages 18 and up

Improving cognitive control in Parkinson's patients using electrical stimulation

Official title: Modulation of Cognitive Control Via Transcranial Continuous Electrical Stimulation of Additional Motor Areas in Parkinson's Patients

Run by Assistance Publique Hopitaux De Marseille · NCT04897633 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing if a special type of brain stimulation can help people with Parkinson's disease improve their ability to control impulsive actions while they are on their medication.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment72 (estimated)
SponsorAssistance Publique Hopitaux De Marseille
Academic / other
Locations1 site (Marseille)
Trial IDNCT04897633 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults over 18 with idiopathic Parkinson's disease who are on dopaminergic treatment and have no significant cognitive deterioration.

Probably not a fit

Patients with uncorrected visual acuity issues, recent changes in psychotropic treatment, or those with certain medical devices like pacemakers may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of transcranial direct current stimulation (tDCS) on cognitive control in patients with Parkinson's disease who are undergoing dopaminergic treatment. The research aims to determine if cathodal stimulation of the Supplementary Motor Areas can enhance the ability to correct impulsive responses, which are often impaired in these patients. Participants will engage in a reaction time task, known as Simon's task, both with and without the stimulation to assess its impact on error correction. The study is designed as a single-center, single-blind, randomized trial.

Why it matters

Potential benefit: If successful, this approach could significantly improve cognitive control and reduce impulsivity in Parkinson's patients, enhancing their overall quality of life.

How similar studies have gone: Previous studies have shown promising results with tDCS in improving cognitive functions, suggesting potential success for this approach in Parkinson's disease.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria for Parkinsonien patients:

* Age\> 18 years old
* Idiopathic Parkinson's disease meeting the diagnostic criteria as defined by Ward and Gibb (1990)
* Patients usually taking dopaminergic treatment.
* No cognitive deterioration with: a Montreal Cognitive Assessment (MoCA) score ≥ 26
* Patient with Parkinson's disease in the advanced motor complications stage for which surgical treatment is being considered

Inclusion Criteria for healthy subjects

* Age\> = 18 years old
* Patient free from Idiopathic Parkinson's Disease
* No cognitive deterioration: MMSE (MiniMentalSate Evaluation)\> 26

Exclusion Criteria for both parkinsonien patients an healthy volunteers:

* Uncorrected altered visual acuity
* Dyschromatopsia (especially color blindness)
* Psychotropic treatment introduced or modified recently (\<1 month)
* Wearing a pacemaker (Pace Maker or Implantable Defibrillator)
* Pregnancy (verified by a urine pregnancy test for women of childbearing age)
* Other central nervous system disease (other parkinsonian syndrome, epilesia, stroke, etc.) or peripheral
* Intracranial metal implants on the cephalic stage and cochlear implant
* Untreated progressive mood or psycho-behavioral disorder
* Severe and poorly controlled eczema

Exclusion criteria for Parkinson's patients only:

* Significant and disabling abnormal movement, not allowing good acquisition of the EMG signal (tremors or dyskinesias)
* Wearer of a Deep Brain Stimulation device (CI at tDCS).

Where it's running

  • Service Neurologie et pathologies du mouvement
    Marseille, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.